Chung ES, Packer M, Lo KH, Fasanmade AA, Willerson JT (2003) Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-, in patients with moderate-to-severe heart failure: results of the anti-TNF therapy against congestive heart failure (ATTACH
Further research to explain the pathological consequences of these variants leading to this specific and consistent phenotype is required
Finally, the viability of purified extracellular Wolbachia following drug exposure was determined using live/dead staining and reinfection assays
Thank you beyond words
Skin homeostasis Skin is one of the most significant protective organs of the body
Current therapies for cognitive loss caused by Alzheimers disease include acetylcholinesterase (AChE) inhibitors and muscarinic or nicotinic receptor ligands